SEARCH

SEARCH BY CITATION

References

  • 1
    D'Alessandro A, Kalayoglu M, Sollinger HW et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991; 51: 157163.
  • 2
    Ploeg RJ, D'Alessandro AM, Knechtle SJ et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 1993; 55: 807813.
  • 3
    Koneru B, Reddy MC, Dela Torre AN, Patel D, Ippolito T, Ferrante RJ. Studies of hepatic warm ischemia in the obese Zucker rat. Transplantation 1995; 59: 942946.
  • 4
    Nakano H, Nagasaki H, Barama A et al. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet. Hepatology 1997; 26: 670678.
  • 5
    Hakamada K, Sasaki M, Takahashi K, Umehara Y, Konn M. Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver. J Surg Res 1997; 70: 1220.
  • 6
    Yamada S, Iida T, Tabata T et al. Alcoholic fatty liver differentially induces a neutrophil-chemokine and hepatic necrosis after ischemia-reperfusion in rat. Hepatology 2000; 32: 278288.
  • 7
    Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 19361943.
  • 8
    Gao W, Connor HD, Lemasters JJ, Mason RP, Thurman RG. Primary nonfunction of fatty livers produced by alcohol is associated with a new, antioxidant-insensitive free radical species. Transplantation 1995; 59: 674679.
  • 9
    Adding LC, Bannenberg GL, Gustafsson LE. Basic experimental studies and clinical aspects of gadolinium salts and chelates. Cardiovasc Drug Rev 2001; 19: 4156.
  • 10
    Selzner M, Rudiger HA, Sindram D, Madden J, Clavien PA. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000; 32: 12801288.
  • 11
    Peralta C, Prats N, Xaus C, Gelpi E, Rosello-Catafau J. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 1999; 30: 14811489.
  • 12
    Fernandez L, Heredia N, Grande L et al. Preconditioning protects liver and lung damage in rat liver transplantation: role of xanthine/xanthine oxidase. Hepatology 2002; 36: 562572.
  • 13
    Serafin A, Rosello-Catafau J, Prats N, Xaus C, Gelpi E, Peralta C. Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002; 161: 587601.
  • 14
    Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155162.
  • 15
    Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 4750.
  • 16
    Sun Z, Klein AS, Radaeva S et al. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 2003; 125: 202215.
  • 17
    Camargo Jr CA, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26: 15131520.
  • 18
    Jaeschke H. Xanthine oxidase-induced oxidant stress during hepatic ischemia-reperfusion: are we coming full circle after 20 years Hepatology 2002; 36: 761763.
  • 19
    Schmekel B, Karlsson SE, Linden M, Sundstrom C, Tegner H, Venge P. Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation 1990; 14: 447454.
  • 20
    Peralta C, Bulbena O, Xaus C et al. Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation 2002; 73: 12031211.
  • 21
    Peralta C, Bartrons R, Riera L et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol 2000; 279: G163G171.
  • 22
    Brown KM, Brems JJ, Moazzam FN, Hartman GG, Gamelli RL, Ding JW. The nitric oxide donor molsidomine improves survival and reduces hepatocyte apoptosis in cholestasis and endotoxemia. J Am Coll Surg 2003; 197: 261269.
  • 23
    Selzner N, Selzner M, Jochum W, Clavien PA. Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. J Hepatology 2003; 39: 5561.
  • 24
    Arvidsson D, Svensson H, Haglund U. Laser-Doppler flowmetry for estimating liver blood flow. Am J Physiol 1988; 254: G471G476.
  • 25
    Kazuo H, Nishida T, Seiyama A et al. Recovery of blood flow and oxygen transport after temporary ischemia of rat liver. Am J Physiol 1998; 275: H243H249.
  • 26
    Langle F, Steininger R, Waldmann E et al. Improvement of cardiac output and liver blood flow and reduction of pulmonary vascular resistance by intravenous infusion of 1-arginine during the early reperfusion period in pig liver transplantation. Transplantation 1997; 63: 12251233.
  • 27
    Peralta C, Bartrons R, Serafin A et al. Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preoconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 2001; 34: 11641173.
  • 28
    Yin DP, Sankary HN, Chong AS et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998; 66: 152157.
  • 29
    Yagnik GP, Takahashi Y, Tsoulfas G, Reid K, Murase N, Geller D. Blockade of the 1- arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology 2002; 36: 573581.
  • 30
    Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105113.
  • 31
    Koken T, Inal M. The effect of nitric oxide on ischemia-reperfusion injury in rat liver. Clin Chim Acta 1999; 288: 5562.
  • 32
    Sola A, Hotter G, Prats N, Xaus C, Gelpi E, Rosello-Catafau J. Modification of oxidative stress in response to intestinal preconditioning. Transplantation 2000; 69: 767772.
  • 33
    Ichimori K, Fukahori M, Nakazawa H, Okamoto K, Nishino T. Inhibition of xanthine oxidase and xanthine dehydrogenase by nitric oxide. Nitric oxide converts reduced xanthine-oxidizing enzymes into the desulfo-type inactive form. J Biol Chem 1999; 274: 77637768.
  • 34
    Unal D, Yeni E, Erel O, Bitiren M, Vural H. Antioxidative effects of exogenous nitric oxide versus antioxidant vitamins on renal ischemia reperfusion injury. Urol Res 2002; 30: 190194.